Assessment of Stuttering Severity in Adults & Adolescences in

Status Active, not recruiting

Clinical Trial Summary

The aim of this study is to assess stuttering severity in both narration and conversation in adults and adolescences in order to determine which situation is more stressful so that more reliable and accurate measures for diagnosis can be done. Also this study will help in determining the best line of management of stuttering.

Clinical Trial Description

Stuttering is a speech disorder in which the flow of speech is disrupted by involuntary repetitions and prolongations of sounds, syllables, words or phrases as well as involuntary silent pauses or blocks. In the world, approximately 1% of the adult population suffer from stuttering. Stuttering has severe impact on the overall quality of the person's life such as anxiety, stress, shame, low self-esteem and negative affectivity .It also affects his educational attainment, his attractiveness and work life as he avoids employment. Stuttering varies in severity, frequency and duration from situation to situation. So its dynamics are best understood within discourse contexts that involve interactions with other people. Clinicians typically rely on spontaneous conversational samples for analyzing speech disfluencies. They have good validity, but the use of a more structured form of speech may allow for more efficient, reliable elicitation of stuttering related behaviours and better understanding of the nature of stuttering. Narration offers a more structured context than conversation because storytellers must weave together information about the characters, the circumstances and actions. Also, narration often contains more complex language than conversation and put the whole responsibility on the speaker for planning and conveying the information to the listener, compared to conversation where two or more speakers co-construct the stream of topics and comments. Thus, narration places more linguistic, cognitive and communicative demands on speakers than does conversation. A research was done on six adult participants and showed that some of them stuttered more during conversation and others stuttered more during narration. ;

Study Design

Related Conditions & MeSH terms

Stuttering

Clinical Trial Details

NCT number	NCT04082104
Study type	Observational
Source	Assiut University
Contact
Status	Active, not recruiting
Phase
Start date	October 1, 2020
Completion date	August 2022

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT01684657` - A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering	Phase 3
Not yet recruiting	`NCT05437627` - Computerized Based Analysis for Detection and Severity Assessment of Stuttering
Completed	`NCT02288598` - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering	N/A
Completed	`NCT00001602` - Genetic Factors Related to Stuttering	N/A
Completed	`NCT04580966` - IBSR Intervention for Adults Who Stutter	N/A
Recruiting	`NCT00148161` - Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering	N/A
Recruiting	`NCT05908123` - Exploring the Nature, Assessment and Treatment of Stuttering	N/A
Completed	`NCT00001551` - Characteristics of Idiopathic Familial Speech Disorders	N/A
Withdrawn	`NCT01315730` - The Effects of Tactile Speech Feedback on Stuttering Frequency	Phase 1
Completed	`NCT00004991` - Study of Brain Activity During Speech Production and Speech Perception	N/A
Recruiting	`NCT05286151` - Network Connectivity and Temporal Processing in Adolescents Who Stutter	N/A
Completed	`NCT00001604` - Genetic Linkage Studies of Stuttering
Recruiting	`NCT00680303` - Spacing Lidcombe Program Clinic Visits	Phase 2
Recruiting	`NCT00709072` - Follow-up of Children After Stuttering Treatment	Phase 2
Completed	`NCT00830154` - A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering	Phase 2/Phase 3
Completed	`NCT03698539` - How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
Completed	`NCT04505696` - Providing Speech Therapy Awareness in Private Schools	N/A
Recruiting	`NCT04929184` - Speech Processing in Stuttering	N/A
Terminated	`NCT00001308` - Central Mechanisms in Speech Motor Control Studied With H215O PET
Completed	`NCT01097161` - Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms